NBTX
Price
$35.95
Change
-$0.12 (-0.33%)
Updated
Jun 18, 10:37 AM (EDT)
Capitalization
1.78B
104 days until earnings call
Intraday BUY SELL Signals
NTLA
Price
$15.10
Change
-$0.10 (-0.66%)
Updated
Jun 18, 12:31 PM (EDT)
Capitalization
2.12B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NBTX vs NTLA

NBTX vs NTLA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NBTX vs. NTLA commentary
Jun 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBTX is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 18, 2026
Stock price -- (NBTX: $35.90 vs. NTLA: $15.20)
Brand notoriety: NBTX and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NBTX: 93% vs. NTLA: 170%
Market capitalization -- NBTX: $1.78B vs. NTLA: $2.12B
NBTX [@Biotechnology] is valued at $1.78B. NTLA’s [@Biotechnology] market capitalization is $2.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $116.49B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBTX’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • NBTX’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, both NBTX and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBTX’s TA Score shows that 2 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • NBTX’s TA Score: 2 bullish, 7 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than NBTX.

Price Growth

NBTX (@Biotechnology) experienced а +7.00% price change this week, while NTLA (@Biotechnology) price change was +24.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.38%. For the same industry, the average monthly price growth was +10.11%, and the average quarterly price growth was +2478.01%.

Reported Earning Dates

NBTX is expected to report earnings on Sep 30, 2026.

NTLA is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+3.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.12B) has a higher market cap than NBTX($1.78B). NTLA YTD gains are higher at: 69.077 vs. NBTX (55.277).
NBTXNTLANBTX / NTLA
Capitalization1.78B2.12B84%
EBITDAN/A-405.09M-
Gain YTD55.27769.07780%
P/E RatioN/AN/A-
RevenueN/A66.1M-
Total CashN/A376M-
Total DebtN/A80.5M-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NBTXNTLA
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 21 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NBTX
Daily Signal:
Gain/Loss:
NTLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JEMA63.650.03
+0.05%
JPMorgan ActiveBuilders EM Eq ETF
DRGN36.400.01
+0.03%
Themes CHN Generative Artfcl Intlgc ETF
MFUS65.78-0.54
-0.81%
PIMCO RAFI Dyn Multi-Factor US Eq ETF
BITW41.10-1.10
-2.61%
Bitwise 10 Crypto Index ETF
UTSL42.70-1.64
-3.70%
Direxion Daily Utilities Bull 3X ETF